Genes behind breast cancer’s spread to the brain identifiedMay 7th, 2009 - 3:30 pm ICT by ANI
London, May 7 (ANI): A group of scientists have identified three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and how.
Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have found that COX2 and HB-EGF - genes that induce cancer cell mobility and invasiveness - are the genetic mediators in the spread of breast cancer to the brain.
They say that a third gene, ST6GALNAC5, has been found to provide cancer cells with the capability of exiting the blood circulation and passing through the blood-brain barrier to enter the brain tissue.
“Our research sheds light on the role these genes play in determining how breast tumor cells break free and, once mobile, how they decide where to attack,” Nature magazine quoted Dr. Joan Massague as saying.
Typically, breast cancer metastasis to the brain occurs years after removal of a breast tumour, suggesting that disseminated cancer cells initially lack the specialized functions needed to overtake the dense network of capillaries that constitute the blood-brain barrier.
This barrier prevents the entry of circulating cells and regulates the transport of molecules into the brain tissue.
Thus, in order to generate brain metastasis, circulating cancer cells need to pass through the blood-brain barrier and interact with the brain microenvironment.
For the study, researchers isolated cancer cells that preferentially targeted the brain from patients with advanced disease.
On combining this approach with gene expression profiling, additional testing in mouse model systems, and analysis of a body of clinical data, the investigators identified certain genes and functions that selectively mediate cancer cell passage through the blood-brain barrier.
They found that ST6GALNAC5, an enzyme that is normally active only in brain tissue, causes a chemical reaction that creates a coating on the surface of breast cancer cells that enhances their ability to breach the blood-brain barrier.
The researchers also noted that COX2 and HB-EGF, which prime breast cancer cells for entrance into the brain, had previously been found to be involved in breast cancer’s spread to the lung.
This indicated a partial sharing of genetic mediators of metastasis to both the brain and lung and may explain the association of brain and lung relapse in women with breast cancer. (ANI)
- 'Self-seeding' of cancer cells may pave way for new therapies - Dec 25, 2009
- Genetic change helps lung tumors spread to other parts of the body - Apr 07, 2011
- Blood protein in lung cancer may help improve diagnosis, treatment - Mar 03, 2011
- Key culprit in breast cancer metastasis identified - Feb 17, 2011
- Genetic key to breast cancer's ability to survive and spread identified - Jul 07, 2009
- What prompts lung cancer to spread - Jul 03, 2009
- Erectile dysfunction drug could enhance delivery of herceptin to brain tumours - May 08, 2010
- Scientists deliver Alzheimer's drug directly into brain - Mar 21, 2011
- 'Low oxygen levels drive cancer growth' - May 06, 2012
- Cancer drugs offer new hope for Crohn's disease and sarcoidosis - Dec 01, 2010
- Cuba launches world's first lung cancer retardant - Sep 07, 2011
- Experimental lung cancer drug may help treat brain, prostate cancer - Jan 04, 2010
- Key component in the spread of lung cancer discovered - Mar 15, 2011
- Gene linked to spread of eye melanoma identified - Nov 05, 2010
- Mechanism involved in breast cancer's spread to bone uncovered - Feb 04, 2011
Tags: blood brain barrier, blood circulation, brain metastasis, brain tissue, breast cancer, breast cancer cells, breast cancer metastasis, breast tumor, cancer cell, dense network, dr joan, gene expression profiling, joan massague, kettering cancer center, memorial sloan kettering, memorial sloan kettering cancer center, nature magazine, sloan kettering cancer, sloan kettering cancer center, tumor cells